Cargando…

An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma

Detalles Bibliográficos
Autores principales:	Reggiani, Francesca, Sauta, Elisabetta, Torricelli, Federica, Zanetti, Eleonora, Tagliavini, Elena, Santandrea, Giacomo, Gobbi, Giulia, Damia, Giovanna, Bellazzi, Riccardo, Ambrosetti, Davide, Ciarrocchi, Alessia, Sancisi, Valentina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022436/ https://www.ncbi.nlm.nih.gov/pubmed/33823854 http://dx.doi.org/10.1186/s12943-021-01357-z

Ejemplares similares

CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer
por: Sauta, Elisabetta, et al.
Publicado: (2021)

The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling
por: Gobbi, Giulia, et al.
Publicado: (2023)

The DNA-helicase HELLS drives ALK(−) ALCL proliferation by the transcriptional control of a cytokinesis-related program
por: Tameni, Annalisa, et al.
Publicado: (2021)

OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer
por: Gugnoni, Mila, et al.
Publicado: (2022)

A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2
por: Vitale, Emanuele, et al.
Publicado: (2022)

KAP1 is a new non-genetic vulnerability of malignant pleural mesothelioma (MPM)
por: Lorenzini, Eugenia, et al.
Publicado: (2022)

HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms
por: Manzotti, Gloria, et al.
Publicado: (2019)

An Innovative Drug Repurposing Approach to Restrain Endometrial Cancer Metastatization
por: Torricelli, Federica, et al.
Publicado: (2023)

Expression of NOTCH1 in thyroid cancer is mostly restricted to papillary carcinoma
por: Piana, Simonetta, et al.
Publicado: (2019)

Computational development of a molecular-based approach to improve risk stratification of endometrial cancer patients
por: Torricelli, Federica, et al.
Publicado: (2018)

Inhibition of BET Proteins and Histone Deacetylase (HDACs): Crossing Roads in Cancer Therapy
por: Manzotti, Gloria, et al.
Publicado: (2019)

A Bayesian data fusion based approach for learning genome-wide transcriptional regulatory networks
por: Sauta, Elisabetta, et al.
Publicado: (2020)

RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN
por: Sancisi, Valentina, et al.
Publicado: (2017)

Suppression of Glioma Progression by Egln3
por: Sciorra, Vicki A., et al.
Publicado: (2012)

Molecular Fingerprints of Malignant Pleural Mesothelioma: Not Just a Matter of Genetic Alterations
por: Lorenzini, Eugenia, et al.
Publicado: (2021)

Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas
por: Gandolfi, Greta, et al.
Publicado: (2017)

Adding pieces to the puzzle of differentiated-to-anaplastic thyroid cancer evolution: the oncogene E2F7
por: Gugnoni, Mila, et al.
Publicado: (2023)

Cadherin 6 Is a New RUNX2 Target in TGF-β Signalling Pathway
por: Sancisi, Valentina, et al.
Publicado: (2013)

Autophagy and epithelial–mesenchymal transition: an intricate interplay in cancer
por: Gugnoni, Mila, et al.
Publicado: (2016)

Spatially resolved, high-dimensional transcriptomics sorts out the evolution of biphasic malignant pleural mesothelioma: new paradigms for immunotherapy
por: Torricelli, F, et al.
Publicado: (2023)

Update on Anaplastic Thyroid Carcinoma: Morphological, Molecular, and Genetic Features of the Most Aggressive Thyroid Cancer
por: Ragazzi, Moira, et al.
Publicado: (2014)

Long non-coding RNA mitophagy and ALK-negative anaplastic lymphoma-associated transcript: a novel regulator of mitophagy in T-cell lymphoma
por: Mularoni, Valentina, et al.
Publicado: (2023)

Transformation by the R Enantiomer of 2-Hydroxyglutarate Linked to EglN Activation
por: Koivunen, Peppi, et al.
Publicado: (2012)

Congenital erythrocytosis – discover of a new mutation in the EGLN1 gene
por: Barradas, João, et al.
Publicado: (2018)

EglN2 positively regulates mitochondrial function in breast cancer
por: Zhang, Jing, et al.
Publicado: (2015)

Effect of EGLN1 Genetic Polymorphisms on Hemoglobin Concentration in Andean Highlanders
por: Yasukochi, Yoshiki, et al.
Publicado: (2020)

Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients
por: Belluti, Silvia, et al.
Publicado: (2021)

Isolated Erythrocytosis Associated With 3 Novel Missense Mutations in the EGLN1 Gene
por: Moore, Joseph A., et al.
Publicado: (2020)

Genetic Analysis of EGLN1 C127S Variant in Taiwanese Parkinson's Disease
por: Chiang, Han-Lin, et al.
Publicado: (2020)

Genome-Wide Knockout Screen Identifies EGLN3 Involving in Ammonia Neurotoxicity
por: Li, Jiequn, et al.
Publicado: (2022)

The bHLH transcription factor DEC1 promotes thyroid cancer aggressiveness by the interplay with NOTCH1
por: Gallo, Cristina, et al.
Publicado: (2018)

The transcription factor NF-Y participates to stem cell fate decision and regeneration in adult skeletal muscle
por: Rigillo, Giovanna, et al.
Publicado: (2021)

Variants of the Low Oxygen Sensors EGLN1 and HIF-1AN Associated with Acute Mountain Sickness
por: Zhang, Enhao, et al.
Publicado: (2014)

Association of EGLN2 rs10680577 Polymorphism with the Risk and Clinicopathological Features of Patients with Prostate Cancer
por: Rahimi, Nahid, et al.
Publicado: (2020)

HIF-PH Encoded by EGLN1 Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia
por: Guo, Wancheng, et al.
Publicado: (2022)

Osteocyte Egln1/Phd2 links oxygen sensing and biomineralization via FGF23
por: Noonan, Megan L., et al.
Publicado: (2023)

Deep Sequencing Analysis Identified a Specific Subset of Mutations Distinctive of Biphasic Malignant Pleural Mesothelioma
por: Torricelli, Federica, et al.
Publicado: (2020)

Not the same thing: metastatic PTCs have a different background than ATCs
por: de Biase, Dario, et al.
Publicado: (2018)

Egln1(Tie2Cre) Mice Exhibit Similar Therapeutic Responses to Sildenafil, Ambrisentan, and Treprostinil as Pulmonary Arterial Hypertension (PAH) Patients, Supporting Egln1(Tie2Cre) Mice as a Useful PAH Model
por: Peng, Yi, et al.
Publicado: (2023)

Combined genetic effects of EGLN1 and VWF modulate thrombotic outcome in hypoxia revealed by Ayurgenomics approach
por: Aggarwal, Shilpi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l08r177eaqdj62n2pehk6j6324